Get Premium to unlock powerful stock data

Woodford Investment Management LLP Buys Evofem Biosciences Inc, Sells Alkermes PLC, Gilead Sciences Inc, Bioverativ Inc

Author's Avatar
insider
Jun 06, 2018
Article's Main Image
Investment company Woodford Investment Management LLP buys Evofem Biosciences Inc, sells Alkermes PLC, Gilead Sciences Inc, Bioverativ Inc, Biogen Inc during the 3-months ended 2018-03-31, according to the most recent filings of the investment company, Woodford Investment Management LLP. As of 2018-03-31, Woodford Investment Management LLP owns 5 stocks with a total value of $1.1 billion. These are the details of the buys and sells.

For the details of Woodford Investment Management LLP's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Woodford+Investment+Management+LLP

These are the top 5 holdings of Woodford Investment Management LLP
  1. Prothena Corp PLC (PRTA) - 11,557,614 shares, 37.95% of the total portfolio. Shares added by 0.25%
  2. Alkermes PLC (ALKS) - 5,270,428 shares, 27.32% of the total portfolio. Shares reduced by 30.52%
  3. Theravance Biopharma Inc (TBPH) - 10,898,879 shares, 23.64% of the total portfolio. Shares added by 1.41%
  4. Biogen Inc (BIIB) - 279,564 shares, 6.85% of the total portfolio. Shares reduced by 24.56%
  5. Evofem Biosciences Inc (EVFM) - 7,465,538 shares, 4.24% of the total portfolio. New Position
New Purchase: Evofem Biosciences Inc (EVFM)

Woodford Investment Management LLP initiated holding in Evofem Biosciences Inc. The purchase prices were between $6.35 and $12.66, with an estimated average price of $8.65. The stock is now traded at around $3.54. The impact to a portfolio due to this purchase was 4.24%. The holding were 7,465,538 shares as of 2018-03-31.

Sold Out: Gilead Sciences Inc (GILD)

Woodford Investment Management LLP sold out a holding in Gilead Sciences Inc. The sale prices were between $72.84 and $88.8, with an estimated average price of $79.49.

Sold Out: Bioverativ Inc (BIVV)

Woodford Investment Management LLP sold out a holding in Bioverativ Inc. The sale prices were between $54.95 and $104.98, with an estimated average price of $91.34.

Reduced: Alkermes PLC (ALKS)

Woodford Investment Management LLP reduced to a holding in Alkermes PLC by 30.52%. The sale prices were between $53.61 and $67.26, with an estimated average price of $58.5. The stock is now traded at around $48.09. The impact to a portfolio due to this sale was -8.54%. Woodford Investment Management LLP still held 5,270,428 shares as of 2018-03-31.

Reduced: Biogen Inc (BIIB)

Woodford Investment Management LLP reduced to a holding in Biogen Inc by 24.56%. The sale prices were between $260.13 and $367.91, with an estimated average price of $310.41. The stock is now traded at around $302.35. The impact to a portfolio due to this sale was -1.95%. Woodford Investment Management LLP still held 279,564 shares as of 2018-03-31.



Here is the complete portfolio of Woodford Investment Management LLP. Also check out:

1. Woodford Investment Management LLP's Undervalued Stocks
2. Woodford Investment Management LLP's Top Growth Companies, and
3. Woodford Investment Management LLP's High Yield stocks
4. Stocks that Woodford Investment Management LLP keeps buying
Rating:
0 / 5 (0 votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles